The U.S. Food and Drug Administration has awarded Breakthrough Device Designation to SPOT-MAS 10, the multi-cancer early detection test developed by Singapore-based Gene Solutions, marking a pivotal ...
Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision ...
Drug hypersensitivity was found in half of a group of children with suspected hypersensitivity and chronic spontaneous urticaria.
With the first phase of the European Union's Cyber Resilience Act (CRA) set to take effect imminently, German-based automated ...
Obesity does not just enlarge fat stores, it appears to rework the body’s wiring and immune landscape in ways scientists have ...
Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...
Santa Marta's first conference on fossil fuel phaseout was watershed moment for energy transition. Its true test comes next ...
A 3-hour WHO Hantavirus emergency Zoom call was held this morning, providing outbreak analysis. It seemed that for every question asked many more questions were raised.
Faraday Copper Corp. ("Faraday" or the "Company") (TSX:FDY)(OTCQX:CPPKF) is pleased to provide an update on the Preliminary ...
Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing ...
As the global obesity crisis continues, GLP-1 receptor agonists have rapidly emerged as one of the most important therapeutic breakthroughs in metabolic medicine. SureNano Science is advancing GEP-44 ...
The 2026 accounting landscape has shifted with the release of Wiley GAAP 2026, introducing critical updates on expense presentation, business combinations, and credit losses that are now central to ...